Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

SBTi commitment

Syngene has taken an important step forward in its contribution towards protecting the planet. We have committed to Science Based Targets (SBTi) which will involve reducing our greenhouse gas (GHG) emissions by 50% by 2033 to align with the Paris Agreement limiting global warming to 1.5°C. With this initiative, Syngene joins the group of over 7000 companies taking action by setting emissions reduction targets in line with climate science.

We have set near-term company-wide emission reductions that will involve:

  • A ten-year target of 50% reduction of GHG emissions from our baseline year of 2023
  • A reduction needed to achieve SBTi target of 13,523 metric tons of CO2 (Scope 1 & 2) by FY33
  • A five-year supplier engagement target to ensure that suppliers representing almost 67% of emissions generated in the supply chain (Scope 3) will also have committed to SBTi targets

How do we plan to achieve these targets?

Syngene will adopt a multi-faceted approach, including investing further in energy savings projects, adopting renewable energy sources and exploring new technologies wherever possible. We have defined a decarbonization pathway that will help to reduce emissions across the value chain.

What are science-based targets?

Science Based Targets initiative (SBTi) is a joint partnership between Carbon Disclosure Project, the United Nations Global Compact, World Resources Institute and the Worldwide Fund for Nature. Science-based targets provide a clear pathway for companies to reduce greenhouse gas (GHG) emissions to mitigate the worst impacts of climate change. Science-based targets give companies a clearly defined path to reduce greenhouse gas emissions in line with limiting global warming to 1.5°C. They define how much and how quickly a business must reduce its emissions to be in line with the Paris Agreement goals.

The different sources of greenhouse gas (GHG) emissions: Scope 1, 2 and 3 emissions is a way of categorising the different kinds of carbon emissions a company generates in the course of running its business.

  • Scope 1 emissions are defined as direct emissions from owned or controlled sources, such as vehicles, generators and boilers.
  • Scope 2 emissions are indirect emissions produced on the company’s behalf including the electricity or energy purchased for heating and cooling buildings
  • Scope 3 emissions cover all emissions generated in the company’s value chain as a result of procuring goods and services. Scope 3 represents most of our total GHG emissions.

Join Syngene.
Be at the cutting-edge of scientific innovation

Your browser does not support this function.

To download, Please share your details

This Website uses Cookies

We use cookies to improve your experience on our site and show you information relevant to your requirements. To find out more, read our Privacy Policy and Cookies Policy.

To view or email, Please share your details view

To download, Please share your details